New patent expiration for Salix Pharms drug RELISTOR
Drug Patent Watch
APRIL 7, 2024
Annual Drug Patent Expirations for RELISTOR Relistor is a drug marketed by Salix Pharms and Salix and is included in two NDAs. It is available from one supplier.
Sun.Apr 07, 2024
98 
Fitting of kinact and KI Values from Endpoint Pre-incubation IC50 Data
Covalent Modifiers
APRIL 7, 2024
Lavleen K. Mader and Jeffrey W. Keillor ACS Medicinal Chemistry Letters 2024 DOI: 10.1021/acsmedchemlett.4c00054 Experiments comprising a “pre-incubation” phase, where enzyme is incubated with inhibitor prior to the addition of assay substrate, are commonly used to evaluate covalent inhibitors, often via discontinuous or “endpoint” IC50 assays. However, due to the lack of mathematical tools to describe its biphasic time-dependent nature, this experiment has thus far been unable to provide kinact
Join 42,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
New patent expiration for Insmed Inc drug ARIKAYCE KIT
Drug Patent Watch
APRIL 7, 2024
Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one NDA. It is available from one supplier.
Which pharmaceutical companies have the most drug patents in Japan?
Drug Patent Watch
APRIL 7, 2024
This chart shows the pharmaceutical companies with the most patents in Japan.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content